요 트립신 억제제가 패혈증 환자의 예후에 미치는 영향
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 문성우 | - |
dc.contributor.author | 홍윤식 | - |
dc.contributor.author | 윤영훈 | - |
dc.contributor.author | 박대원 | - |
dc.contributor.author | 장익진 | - |
dc.contributor.author | 임성익 | - |
dc.contributor.author | 이성우 | - |
dc.date.accessioned | 2021-09-08T22:15:35Z | - |
dc.date.available | 2021-09-08T22:15:35Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 1226-4334 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/121183 | - |
dc.description.abstract | Purpose: We purposed to determine the effects of urinary typsin inhibitor (ulinastatin) on the outcomes of severe sepsis and septic shock patients. Methods: This is a prospective case control study of severe sepsis and septic shock patients who visited emergency department of university hospital from January 2005 to June 2008. For study group, 100,000 U of ulinastatin was initially infused and then additional infusions of ulinastatin were determined by the mean arterial pressure. We compared the predicted mortality and the actual in-hospital mortality between the ulinastatin group and the control group. We also compared the improvement of the SOFA score according to time between the groups. Results: There were 43 patients in the ulinastatin group and 126 patients in the control group. The predicted mortality and the actual mortality of the ulinastatin group were 31.2% and 18.6%, respectively. The predicted and actual mortalities of the control group were 33.1% and 27.0%, respectively. The improvement of the SOFA score for the ulinastatin group was 6.8±3.9 and 5.0±4.5 at 0 and 24 hours (p<0.001), 6.5±3.7 and 3.9±4.3 at 0 and 48 hours (p<0.001) and, 6.3±3.6 and 3.0±4.1 at 0 and 72 hours (p<0.001). For the control group, the change of the SOFA score was 4.9±2.9 and 5.8±4.1 at 0 and 24 hours (p=0.003), 5.0±2.8 and 5.1±4.2 at 0 and 48 hours (p=0.760) and, 4.8±2.7 and 4.3±4.1 at 0 and 72 hours (p=0.105). Conclusion: The ulinastatin group showed significantly lower mortality than the predicted mortality and the ulinastatin group’s SOFA score was improved in the early hospital days. | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.publisher | 대한응급의학회 | - |
dc.title | 요 트립신 억제제가 패혈증 환자의 예후에 미치는 영향 | - |
dc.title.alternative | The Effects of Urinary Trypsin Inhibitor on the Outcomes of Severe Sepsis and Septic Shock Patients | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 문성우 | - |
dc.contributor.affiliatedAuthor | 홍윤식 | - |
dc.contributor.affiliatedAuthor | 이성우 | - |
dc.identifier.bibliographicCitation | 대한응급의학회지, v.20, no.1, pp.80 - 85 | - |
dc.relation.isPartOf | 대한응급의학회지 | - |
dc.citation.title | 대한응급의학회지 | - |
dc.citation.volume | 20 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 80 | - |
dc.citation.endPage | 85 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001321016 | - |
dc.description.journalClass | 2 | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Septic shock | - |
dc.subject.keywordAuthor | Severe sepsis | - |
dc.subject.keywordAuthor | Urinary trypsin inhibitor | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.